Skip to Content

Resize text:

A A A

Research & Clinical Trials

Find a Doctor


To search Houston doctors, please select a specialty & submit your Zip Code below.

Advanced Search
Search by Doctor's Name

Schedule Now


To schedule an appointment online, select provider type, service and submit your ZIP code below.

Appointment available in next 7 days
Advanced Search

Preventing Stroke and Non-Central Nervous System Systemic Embolism in Patients With Non-Valvular Atrial Fibrillation

Lead Physician: Sherman Tang, MD, Memorial Hermann Southwest

A Prospective, Randomized, Double-Blind, Double-Dummy, Parallel-Group, Multicenter, Event-Driven, Non-inferiority Study Comparing the Efficacy and Safety of Once-Daily Oral Rivaroxaban (BAY 59-7939) With Adjusted-Dose Oral Warfarin for the Prevention of Stroke and Non-Central Nervous System Systemic Embolism in Subjects With Non-Valvular Atrial Fibrillation

Sponsor: Johnson & Johnson Pharmaceutical Research & Development

Initiation Date: 2007-12-13

For more information: Contact Julia Powers, RN, MSN, CCRP, at 713.456.4011 or Kristin Chandler, RN, CCRP, at 713.456.4073.

Protocol: 39039039AFL3001



-x